Press Releases June 26, 2026 07:00 AM

Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026

Balchem Corporation to Present at CJS Securities 26th Annual New Ideas Summer Conference in July 2026

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
BCPC

Balchem Corporation, a global specialty ingredient manufacturer serving health and nutrition markets, announced it will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives including the CEO, CFO, and Senior Director of Investor Relations will represent the company at the event.

Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
BCPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Balchem Corporation is a global manufacturer specializing in ingredients for health and nutrition sectors.
  • The company operates three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
  • Senior leadership will participate in the upcoming investor conference, providing opportunities for investor engagement and corporate updates.

MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact: Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)

Risks

  • The press release does not disclose any new financial results or business developments, limiting immediate impact on investor sentiment.
  • Market reaction may depend on the content and disclosures made during the conference, which remain unknown.
  • The company's performance is tied to global health, nutrition, pharmaceutical, agricultural, and specialty chemical markets, which can be affected by economic and regulatory factors.

More from Press Releases

Golar LNG Announces Pricing of $500 Million Offering of Senior Notes due 2031 Sep 24, 2026 Battalion Oil to Release Investor Presentation on Sept. 30 Sep 24, 2026 Ormat Selected for Approximately $35 Million in U.S. Department of Energy Funding to Advance EGS and Hydrothermal Development Sep 24, 2026 Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act Sep 24, 2026 Tyson Foods Announces Fourth Quarter Earnings Conference Call and Webcast Sep 24, 2026